Green food

• PRESTIGIOUS IEEE MEDAL OF HONOR PRIZE IS INCREASED TO $2 MILLION

  

  The Highest Award for Exceptional Technology,Engineering,and Science Contributions Given by World\'s Largest Technical Professional Organization Now Ranks

  09-19

  Details

• VISTA 25th Birthday Eye Carnival: A Rockin' Celebration of Vision and 25 Years of Excellence

  

  PETALING JAYA,Malaysia,Sept. 19,2024-- Get ready to rock out with VISTA Eye Specialist (\'VISTA\') as we celebrate our 25th Birthday with the "See The World Like A Rockstar" Eye Carnival! Th

  09-19

  Details

• Watsons-Marlow unveils Qdos™ H-FLO and WMArchitectTM :Innovating fluid solutions for the chemical and biopharmaceutical industries respectively

  

  SINGAPORE,Sept. 19,2024--Watson-Marlow Fluid Technology Solutions (WMFTS),aworld leader in manufacturing peristaltic pump and associated fluid path technologies for process industries and life science

  09-19

  Details

• DP WORLD TEES OFF PARTNERSHIP WITH TOMMY FLEETWOOD AHEAD OF BMW PGA

  

  SURREY,England,Sept. 18,2024-- DP World Europe has unveiled a new campaign featuring global brand ambassador Tommy Fleetwood ahead of the BMW PGA Championship at Wentworth.

  09-19

  Details

• Unveil the Magic of Fall with Suika Game's '[Autumn Version] Special Skin Pack'

  

  TOKYO,Sept. 17,2024-- Aladdin X Inc.,a subsidiary of the award-winning projector and laser projector brand XGIMI,iscelebrating the autumn with the global launch of the \'[Autumn Version] Special Skin

  09-18

  Details

• Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and Once-Daily Oral Tablet for the Treatment of Obesity

  

  - ASC30 is the first and only small molecule GLP-1 receptor (GLP-1R)agonist that can be dosed once-monthly subcutaneously and once-daily orally to treat obesity

  09-18

  Details

• See-Mode Technologies Receives FDA Clearance for Thyroid Ultrasound AI Analysis and Reporting Software

  

  MELBOURNE,Australia,Sept. 17,2024-- See-Mode Technologies,a global innovator in AI for ultrasound imaging,today announced the receipt of 510(k) clearance from the U.S. Food and Drug Administration (F

  09-18

  Details

• Mega Matrix Announces That the Short Drama "Revenge Beyond the Grave", Will Be Released on September 18 at FlexTV

  

  PALO ALTO,Calif.,Sept. 18,2024-- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU),today announced that it will launch its revenge short drama "Revenge Beyond t

  09-18

  Details

• 2025 Tech Trends Report: Info-Tech Research Group Unveils New Insights on the Future of AI, Quantum Computing, and Cybersecurity

  

  Info-Tech\'s newly released Tech Trends 2025 report outlines six critical trends that will shape the future of IT,from the rise of AI avatars to the urgent need for post-quantum cryptography. The ann

  09-18

  Details

• Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

  

  NANJING,China,Sept. 14,2024-- On September 2,2024,Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets),an innovative dr

  09-17

  Details